Abacus Health Products (OTCMKTS:ABAHF) Shares Down 5.1% – Time to Sell?

Abacus Health Products Inc (OTCMKTS:ABAHF)’s stock price traded down 5.1% on Thursday . The stock traded as low as $4.60 and last traded at $4.84. 9,300 shares were traded during trading, a decline of 9% from the average session volume of 10,164 shares. The stock had previously closed at $5.10.

Abacus Health Products Stock Performance

The stock’s 50 day simple moving average is $4.84 and its 200-day simple moving average is $4.84.

Abacus Health Products Company Profile

Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.

Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms.